Learn More
Gibco™ Human IL-17A Recombinant Protein
Description
Carrier-Free Reconstitution: We recommend that the vial be briefly centrifuged prior to opening to bring the contents to the bottom. Lyophilized human IL-17A should be reconstituted in sterile, distilled water to a concentration of 0.1-1.0 mg/mL. For maximal stability, a carrier protein, such as 0.1-1.0% BSA, may be included. The reconstituted protein should be apportioned into working aliquots and stored at ≤-20°C. Further dilutions should be made in low endotoxin medium or buffered solution with FBS or tissue culture grade BSA. Storage: For maximal stability, store this lyophilized preparation at ≤-20°C, preferably desiccated. For shipment and short term storage (up to 2 weeks), storage at 2°C to 8°C is sufficient. Reconstituted human IL-17A should be stored at ≤-20°C (not in a frost-free freezer). Keep freeze-thaw cycles to a minimum.
Specifications
Specifications
| Accession Number | Q16552 |
| For Use With (Application) | Bioactivity |
| Formulation | Protein with no preservative |
| Gene ID (Entrez) | 3605 |
| Molecular Weight (g/mol) | 15.5 kDa |
| Name | Human IL-17A |
| Purification Method | Purified |
| Quantity | 100 μg |
| Storage Requirements | -20°C |
| Regulatory Status | RUO |
| Show More |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.